[1]
Oldenburg, J. , Goldmann, G. , Marquardt, N., Horneff, S., Klein, C. , Albert, T. and Perera, R. 2021. Real-world clinical experience of extended half-life recombinant factor VIII Fc fusion protein (rFVIIIFc) in comparison to conventional factor products in patients with severe hemophilia A . Journal of Current Medical Research and Opinion. 4, 05 (May 2021), 950–960. DOI:https://doi.org/10.15520/jcmro.v4i05.422.